📰 Breakthrough Device News
Page 4 - Breakthrough Device News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Breakthrough Device. Real-time updates on events, politics, business and more.
February 14, 2024
SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative technologies and science-based treatments to address the global myopia epidemic, today announced that the U.S. Food and Drug Administration (FDA) has...
February 8, 2024
WATERTOWN, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to
February 7, 2024
Envoy Medical’s FDA Approved Esteem® Fully Implanted Active Middle Ear Hearing Device May Now Have an Opportunity to be a Coverable Benefit WHITE BEAR LAKE, Minnesota, Feb. 07, 2024 -- ...
February 7, 2024
Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
February 2, 2024
The company's new product, Visage Ease VP, will allow users to examine diagnostic images in an immersive world via Apple's augmented reality headset.
January 31, 2024
The PBC Biomed affiliate company has developed an injectable bone filler to fix joint fractures or defects. A key medical product by Biomimetic Innovations…
January 31, 2024
Biomimetic Innovations' injectable bone filler has been granted Breakthrough Designation by the FDA, giving a boost to its development.
January 30, 2024
Envoy Medical®, Inc. , a revolutionary hearing health company focused on fully implanted hearing systems, will be participating in The Microcap Conference, which will take place January 30, 31,...
January 30, 2024
Most Alzheimers drug trials are using paper measurement tools developed in the 1980s and 1990s. Neurotechnology can do better for patients, while saving us billions.
January 29, 2024
Fractyl Health, Inc., in a filing with the U.S. Securities and Exchange Commission, on Monday said it expects to price the initial public offering or IPO of 7.33 million shares to be between $14.